SCHEMBL2331815

SCHEMBL2331815

O=P(O)(O)CC1CCCCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 1/20 0.50
MMP2 P08253 4/20 0.47
CA12 O43570 3/20 0.47
CA1 P00915 3/20 0.47
CA2 P00918 3/20 0.47
CA9 Q16790 3/20 0.47
MMP1 P03956 2/20 0.47
MMP3 P08254 2/20 0.47
MMP8 P22894 2/20 0.47
MMP9 P14780 1/20 0.47
FDPS P14324 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
THRB P10828 1/20 0.41
ALOX15 P16050 1/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 1/20 0.41
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL7648271 0.97 METAP1 (0.48) METAP1MMP2CA12CA1CA2
Phosphoric Acid SCHEMBL11497465 0.97 METAP1 (0.48) METAP1MMP2CA12CA1CA2
SCHEMBL10941895 0.97 METAP1 (0.48) METAP1MMP2CA12CA1CA2
SCHEMBL14157910 0.92
Phosphonic Acid SCHEMBL11496941 0.91 METAP1 (0.44) METAP1MMP2CA12CA1CA2
SCHEMBL21925045 0.86
SCHEMBL8732595 0.80 MMP2 (0.48) METAP1MMP2CA12CA1CA2
SCHEMBL5535929 0.80 MMP2 (0.44) METAP1MMP2CA12CA1CA2
SCHEMBL6828011 0.80 METAP1 (0.47) METAP1MMP2CA12CA1CA2
SCHEMBL6823936 0.80 METAP1 (0.47) METAP1MMP2CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240393684-A1 METHOD OF FORMING PATTERNS SAMSUNG SDI CO., LTD. (KR) 2024-11-28 US claimed
CN-119024654-A Method for forming pattern 三星SDI株式会社 2024-11-26 CN claimed
US-10060887-B2 Field sampling kit and methods for collecting and detecting alkyl methylphosphonic acids THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 2018-08-28 US claimed
US-6403329-B1 MIXING AND REACTING ALKYLOXY METHYLPHOSPHONIC ACID WITH DEHYDRATION AGENT TO MAKE CHOLINESTERASE INHIBITOR THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY 2002-06-11 US claimed
US-5935862-A DETECTING PRESENCE OF CHEMICAL WARFARE AGENTS BY APPLYING LIQUID SAMPLE TO CHROMATOGRAPHIC ADSORBANT MATERIAL AND DETECTOR AGENT USING MICROCAPILLARY TUBE, FORMING CHROMOGENIC INDICATOR; PORTABLE, SENSITIVE, ACCURATE THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 1999-08-10 US claimed
EP-0074296-B1 FLAME-RESISTANT RESINOUS COMPOSITION CONTAINING A POLYCARBONATE, A HEMI-ESTER OF PHOSPHONIC ACID AND OPTIONALLY OTHER ADDITIVES AND/OR FILLERS, AND HEMI-ESTERS OF PHOSPHONIC ACID ATO CHIMIE, Société Anonyme dite: (FR) 1985-11-06 EP claimed
EP-0074296-A1 Flame-resistant resinous composition containing a polycarbonate, a hemi-ester of phosphonic acid and optionally other additives and/or fillers, and hemi-esters of phosphonic acid ATO CHIMIE, Société Anonyme dite: (FR) 1983-03-16 EP claimed
WO-2026106403-A1 NOVEL NRF2 ACTIVATOR AND USE THEREOF 나손사이언스(주) 2026-05-21 WO disclosed
US-12552715-B2 Plate-like alumina particle and method for manufacturing plate-like alumina particle DIC CORPORATION (JP) 2026-02-17 US disclosed
US-12503606-B2 Composite particle and method of producing composite particle DIC CORPORATION (JP) 2025-12-23 US disclosed
US-12486176-B2 Composite particle and method of producing composite particle DIC CORPORATION (JP) 2025-12-02 US disclosed
US-12459830-B2 Plate-like alumina particle and method for manufacturing plate-like alumina particle DIC CORPORATION (JP) 2025-11-04 US disclosed
US-20240393684-A1 METHOD OF FORMING PATTERNS SAMSUNG SDI CO., LTD. (KR) 2024-11-28 US disclosed
EP-1173170-A4 PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO INC (US) 2002-05-29 EP disclosed
EP-1173170-A1 PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Merck & Co., Inc. (US) 2002-01-23 EP disclosed
WO-2000059503-A1 PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-10-12 WO disclosed
US-5935862-A DETECTING PRESENCE OF CHEMICAL WARFARE AGENTS BY APPLYING LIQUID SAMPLE TO CHROMATOGRAPHIC ADSORBANT MATERIAL AND DETECTOR AGENT USING MICROCAPILLARY TUBE, FORMING CHROMOGENIC INDICATOR; PORTABLE, SENSITIVE, ACCURATE THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 1999-08-10 US disclosed
EP-0074296-B1 FLAME-RESISTANT RESINOUS COMPOSITION CONTAINING A POLYCARBONATE, A HEMI-ESTER OF PHOSPHONIC ACID AND OPTIONALLY OTHER ADDITIVES AND/OR FILLERS, AND HEMI-ESTERS OF PHOSPHONIC ACID ATO CHIMIE, Société Anonyme dite: (FR) 1985-11-06 EP disclosed
EP-0123300-A2 Complexing of biologically active or functional compounds and methods of preparing and utilizing same ENZO BIOCHEM, INC. (US) 1984-10-31 EP disclosed
EP-0074296-A1 Flame-resistant resinous composition containing a polycarbonate, a hemi-ester of phosphonic acid and optionally other additives and/or fillers, and hemi-esters of phosphonic acid ATO CHIMIE, Société Anonyme dite: (FR) 1983-03-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12552715-B2 Plate-like alumina particle and method for manufacturing plate-like alumina particle F9, VPS35, CD209 METAP1 2730/4885MMP2 2082/4885CA12 615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.